You just read:

The Zacks Analyst Blog Highlights: Teva Pharmaceutical Industries, Novartis, Biogen Idec, Actavis and VimpelCom

News provided by

Zacks Investment Research, Inc.

Jan 30, 2014, 09:30 EST